SPY425.10+2.50 0.59%
DIA341.98+3.20 0.94%
IXIC14,369.71+97.98 0.69%

Akouos Appoints Development Chief

05/10/2021 00:31

04:27 AM EDT, 05/10/2021 (MT Newswires) -- Akouos (AKUS), a precision genetic medicine company, said Friday that Kathy Reape has been named chief development officer.

Reape most recently served as chief medical officer at Spark Therapeutics.

Price: 13.17, Change: +0.19, Percent Change: +1.46